Gelteq Limited (GELS) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

Gelteq Limited (GELS) closed at USD 0.45 on 2026-10-14, a change of -63.1 % over the past year, with a market capitalization of USD 4.61M.

Gelteq Limited recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Gelteq Limited key figures

Previous close

USD 0.45 (2026-10-14)

1-year change

-63.1 %

Market cap

USD 4.61M

Enterprise value

USD 9.92M

P/E ratio (trailing)

-1.05

P/E ratio (forward)

n/a

EPS (trailing)

-0.41

EPS (forward)

n/a

PEG ratio

n/a

Price to book

0.49

Revenue growth

48.9 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.06

Employees

7

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Gelteq Limited

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Gelteq Limited and compare it with other stocks.